Mind Medicine MindMed Inc

For the period ended Mar 31, 2024. Filed May 8, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 8, 2024

DFTX$35.39+6.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

	March 31, 2024(unaudited)	December 31, 2023
Assets
Current assets:
Cash and cash equivalents	$252,332	$99,704
Prepaid and other current assets	3,139	4,168
Total current assets	255,471	103,872
Goodwill	19,918	19,918
Intangible assets, net	—	527
Other non-current assets	144	224
Total assets	$275,533	$124,541
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable	$7,595	$4,136
Accrued expenses	9,974	11,634
2022 USD Financing Warrants	47,700	16,476
Total current liabilities	65,269	32,246
Credit facility, long-term	14,190	14,129
Other liabilities, long-term	15	32
Total liabilities	79,474	46,407
Commitments and contingencies (Note 9)
Shareholders' Equity:
Common shares, no par value, unlimited authorized as ofMarch 31, 2024 and December 31, 2023; 71,163,720 and 41,101,303 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	—	—
Additional paid-in capital	539,823	367,991
Accumulated other comprehensive income	836	343
Accumulated deficit	(344,600)	(290,200)
Total shareholders' equity	196,059	78,134
Total liabilities and shareholders' equity	$275,533	$124,541

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.